X-47624394-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001145252.3(CFP):āc.1291T>Gā(p.Phe431Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000414 in 1,207,903 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.0000091 ( 0 hom., 0 hem., cov: 21)
Exomes š: 0.0000036 ( 0 hom. 1 hem. )
Consequence
CFP
NM_001145252.3 missense
NM_001145252.3 missense
Scores
4
8
5
Clinical Significance
Conservation
PhyloP100: 5.33
Genes affected
CFP (HGNC:8864): (complement factor properdin) This gene encodes a plasma glycoprotein that positively regulates the alternative complement pathway of the innate immune system. This protein binds to many microbial surfaces and apoptotic cells and stabilizes the C3- and C5-convertase enzyme complexes in a feedback loop that ultimately leads to formation of the membrane attack complex and lysis of the target cell. Mutations in this gene result in two forms of properdin deficiency, which results in high susceptibility to meningococcal infections. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFP | NM_001145252.3 | c.1291T>G | p.Phe431Val | missense_variant | 9/9 | ENST00000396992.8 | NP_001138724.1 | |
CFP | NM_002621.2 | c.1291T>G | p.Phe431Val | missense_variant | 10/10 | NP_002612.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000911 AC: 1AN: 109818Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 32078
GnomAD3 genomes
AF:
AC:
1
AN:
109818
Hom.:
Cov.:
21
AF XY:
AC XY:
0
AN XY:
32078
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 183332Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67770
GnomAD3 exomes
AF:
AC:
3
AN:
183332
Hom.:
AF XY:
AC XY:
1
AN XY:
67770
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000364 AC: 4AN: 1098085Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 1AN XY: 363455
GnomAD4 exome
AF:
AC:
4
AN:
1098085
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
363455
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000911 AC: 1AN: 109818Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 32078
GnomAD4 genome
AF:
AC:
1
AN:
109818
Hom.:
Cov.:
21
AF XY:
AC XY:
0
AN XY:
32078
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | The c.1291T>G (p.F431V) alteration is located in exon 10 (coding exon 9) of the CFP gene. This alteration results from a T to G substitution at nucleotide position 1291, causing the phenylalanine (F) at amino acid position 431 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 22, 2023 | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CFP protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 2381972). This sequence change replaces phenylalanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 431 of the CFP protein (p.Phe431Val). This variant is present in population databases (rs752325590, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with CFP-related conditions. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MutPred
Gain of disorder (P = 0.0596);Gain of disorder (P = 0.0596);
MVP
MPC
1.9
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at